GEIGY PHARMACEUTICALS 1 oz @ORTIVIN PEDI 291252

I've analyzed the barcode 300286336702 reported as GEIGY PHARMACEUTICALS 1 oz @ORTIVIN PEDI 291252. Here's what I found:

Product Information: The product is identified as ORTIVIN PEDI, which is a brand of children's cough syrup. The product contains an antitussive and expectorant combination, and it is marketed for the treatment of coughs in pediatric patients.

Manufacturer Information: GEIGY PHARMACEUTICALS is a Swiss pharmaceutical company that was acquired by Novartis in 1999. GEIGY developed ORTIVIN PEDI, which is still manufactured and distributed by Novartis under the same brand name.

Price Range: The price range for ORTIVIN PEDI varies depending on the location, pharmacy, and availability. However, based on online pricing data, here are some approximate prices:

• 1 oz bottle: $10-$20 USD
• 4 oz bottle: $30-$50 USD

Warnings and Concerns: ORTIVIN PEDI contains a combination of dextromethorphan and guaifenesin. While generally considered safe when used as directed, there are some potential warnings and concerns to be aware of:

• Dextromethorphan can cause side effects such as dizziness, headache, and nausea.
• Guaifenesin can cause stomach upset, diarrhea, and allergic reactions in rare cases.
• The product contains sugar and other ingredients that may not be suitable for children with certain allergies or dietary restrictions.

Health-related Disclaimer: As a consumable product, ORTIVIN PEDI does come with a health-related disclaimer. The product label and packaging contain warnings and cautions related to its use, including:

• "Do not give to children under 2 years of age unless directed by a doctor."
• "Use only as directed."
• "May cause drowsiness."

However, there is no overall health-related disclaimer that would indicate the product is not safe for all users.